Tagayan, Nor-aiza U.

HRN: 01-70-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CO-AMOXICLAV 625MG (TAB)
09/25/2025
10/01/2025
PO
625mg
BID
Sp 1 LTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines